Clinical Trials Logo

Clinical Trial Summary

The goal of this pilot study is to investigate the effect of an evidence-based adherence promoting intervention on exercise adherence of patients with osteoporosis. For this reason, a randomized controlled pilot trial with an intervention period of three months will be conducted. Question I: To which extent does an adherence-promoting intervention (AERO) have an effect on adherence to long-term exercise programs in patients with osteoporosis compared to conventional standard care with home-based exercise therapy? Objective II: Does the AERO Intervention influence fall risk factors such as functional lower extremity strength and fear of falling compared to conventional standard care plus home-based exercise therapy in patients with osteoporosis? Patients will be randomized to two groups: an intervention and a control group. Both groups will receive instructions for a home exercise program (HEP) during six physical therapy (PT) sessions. The intervention group will receive a HEP and additionally the so-called AERO (Adherence for Exercise Rehabilitation in Older people) intervention within 6 PT-Sessions. The AERO program is a feasible intervention for boosting the exercise adherence of older people. The AERO intervention is an evidence-based adherence promoting intervention approach to help patients adhere to an exercise program. The control group will receive six PT sessions as "standard care". In regular clinical practice in Germany "standard care" for people with osteoporosis include measures such as home exercise programs, mobilisations, soft tissue techniques, or training with gym equipment. This will be delivered based on each PT clinical reasoning with no additional motivation for adherence to the exercise program.


Clinical Trial Description

"Osteoporosis is a disease which causes the bones to become porous, weak and fragile. The result: a higher risk of broken bones, known as fragility fractures. Pain, fear of falling as well as reduced physical and social activity are also known complications that immensely impact the quality of life of patients with osteoporosis. A common treatment goal in osteoporosis is the reduction of falls and fractures. Next to medication and dietary changes physical activity plays an important role in managing osteoporosis. The effectiveness of physical activity in people with osteoporosis has already been established. Strengthening exercises targeting the lower extremities have shown the largest effect for the bone mineral density (BMD) measured at the neck of the femur. These results are also enclosed in the German Osteoporosis Guideline: enhancing strength, coordination, and balance by promoting regular physical activity as part of the prevention and basic treatment plan for osteoporosis. To achieve these goals, exercise needs to be executed thoroughly for a prolonged period of time and therefore treatment adherence to these exercise programs is crucial. Adherence itself is defined by the World Health Organization (WHO) as: ".... 'the extent to which a person's behavior corresponds with agreed recommendations from a healthcare provider." People with osteoporosis often have problems to adhere with any exercise program prescribed. About 50% of the participants of exercise programs quit these programs after six months. Rodrigues et al., analyzed 54 studies using exercises and reported adherence rates between 51% and 100%. Multiple reasons, which are being referred to as barriers (e.g., lack of time, family priorities, monetary issues) are proposed as being linked to non-adherence. Therefore, measures that promote adherence towards these regimens are needed to ensure the long-term effects and benefits of exercise programs. It is crucial that patients conform to the recommendations made by the health care providers. The best exercise program is unsuccessful if it is not being followed. Based on the literature and a previous review conducted by our team, only a few studies were found that looked at ways for improving adherence in individuals with osteoporosis. However, none of these studies investigated adherence as a primary outcome but only as a secondary outcome in regard to a specific exercise program. One study identified by the authors through manual search was the Adherence for Exercise Rehabilitation in older people (AERO) intervention. Although not targeted to subjects with osteoporosis, this evidence-based intervention was created to enhance Adherence for Exercise Rehabilitation in older people. However, this program has only been implemented in United Kingdom using other populations. Thus, the main objective of this project will be to determine whether an adherence enhancing intervention (AERO intervention) would improve the exercise adherence of people with osteoporosis doing a home exercise program compared to conventional standard care using home-based exercise therapy in a German context. To the knowledge of the authors this would be the first study which examines exercise adherence as primary outcome measure. Another advantage of the chosen design is that it is the first study design known by the authors targeting subjects with osteoporosis in which the control group does not receive an adherence-promoting intervention and therefore the effect of this measure can be derived. With this study design group differences and possible effects of the AERO-Intervention can be demonstrated more easily. Question I: To which extent does an adherence-promoting intervention (AERO) have an effect on adherence to long-term exercise programs in patients with osteoporosis compared to conventional standard care with home-based exercise therapy? Question II: Does the AERO Intervention influence fall risk factors such as functional lower extremity strength and fear of falling compared to conventional standard care plus home-based exercise therapy in patients with osteoporosis? The goal of this pilot study is to investigate the effect of an evidence-based adherence promoting intervention to the exercise adherence of osteoporosis patients. For this reason, a randomized controlled pilot trial with an intervention period of three months will be conducted. The baseline assessment will be conducted before the randomization in the first physical therapy (PT) session. After completing baseline assessments, then the patient will be immediately randomized to each of the interventions. The intervention period starts in both groups with the first treatment and lasts three months. The final assessment will be conducted 12 weeks after the first PT treatment, the appointment for the final assessment will be scheduled after 6 PT sessions. Patients will be randomly assigned into a control group and an intervention group using a computer program generated by an external party. In order to warrant allocation concealment, numbered, opaque, and sealed envelopes will be used. To ensure that both patient groups are neutral about the study's objective, the patients are being told that both treatments are equally effective. Therefore, the patient is not biased beforehand knowing that he/she is in the intervention or the control group. Group description: The intervention group will receive a HEP and additionally the so-called AERO intervention within 6 PT-Sessions. The AERO program is a feasible intervention for boosting the exercise adherence of older people. The AERO intervention is an evidence-based adherence promoting intervention approach to help patients adhere to an exercise program. The AERO intervention is theoretically underpinned by the Behavioural Change Wheel (BCW) with the COM-B Model in its center (see link below). The authors choose this intervention for their study because of the robust theoretical underpinning. The AERO intervention consists of various parts. Before their first physiotherapy appointment, patients will be asked to respond to four specific questions in the waiting room to guide the treatment. After this, they will receive a routine physiotherapy assessment and treatment which includes the instruction of a HEP in addition to usual care for managing osteoporosis. The therapist can use the answers from the aforementioned questions and any following discussion in developing the HEP. The number of exercises given should minimally be three to maximum six and they should be performed at least three days per week. Besides this, the therapists should advise their patients to exercise regularly. Combined with the given home exercise program, the patient should be able to reach the recommended 150 minutes of the WHO. Nevertheless, for the purpose of this study and ensuring an accurate representation of adherence, we will collect information about adherence with their home exercise program (type of exercise, repetitions and sets). The additional activities will not be considered on this outcome. After the assessment and hand-out of the home-exercise program, patients in the intervention group are asked to answer another set of questions which explores their subjective abilities of the COM-B Model (capability, opportunity or motivation) of undertaking the exercise program. Based on these answers and with the help of further discussions with the patient, the physiotherapist makes an assessment which domains of the COM-B model might be useful to target. In the following PT-sessions the therapist suggests one or more specific actions to enhance adherence. The participants have to attend at least 4 out of 6 sessions of the program to be considered compliant with the therapy; otherwise, they will be analyzed as not compliant. The control group will receive six PT sessions as "standard care". In regular clinical practice "standard care" for people with osteoporosis include measures such as home exercise programs, mobilisations, soft tissue techniques, or training with gym equipment. The HEP in the control group is based on the physical assessment of the physical therapist and the individual problems of the patient. If a patient presents with, e.g., reduced mobility of the spine, a suitable exercise will be applied. The therapists in the control group do not have any restrictions for the exercises chosen, they just need to be able to be performed at home without any major equipment. The therapist is advised to tell the patient how often they must exercise throughout the week. The participants have to attend at least 4 out of 6 sessions of the control program to be considered compliant with the therapy; otherwise, they will be analyzed as not compliant. Statistical Analysis: The demographics of study participants will be described and will be presented in a tabular fashion (i.e., height, weight, BMI, age and sex) and separated by groups. Mean (SD), median (interquartile range), frequencies will be used to describe the population. To investigate the first objective of this study, if adherence-promoting interventions (AERO) influence adherence to long-term exercise programs in patients with osteoporosis compared to conventional exercise therapy, two analyses will be performed. One analysis will include within group and the other will include between groups. Due to the small sample size, we anticipate that our data will not be normally distributed, and therefore we will conduct nonparametric tests to determine our p values. These analyses will be complemented by parametric tests to confirm results (when possible). To determine differences before and after each individual treatment, we will conduct a Wilcoxon matched pairs test or a bootstrapped dependent t-test for the adherence scale. Calculation of the effect size for each group will be also performed. To determine differences between treatments, we will conduct a Mann-Whitney test or a bootstrapped independent t-test for the adherence scale. The alpha Level will be set to p=0.05 for all analyses. The same analysis will be conducted for secondary outcomes such as the 30s chair stand and the FES-I. The data of the diary will be analyzed with the Chi-Square Test. To investigate the second objective, if the AERO intervention influences the fear of falling and increases the functional lower extremity strength, the author plans to analyze the data for differences between the baseline data and the data after the observation period within one group. Therefore, authors plan to analyze the 30s chair stand and the FES-I via Wilcoxon-Rank Test. For differences in the data between the two groups the authors plan to analyze the OEE-2 and the 30s chair stand via Mann Whitney U. Alpha Level will be set to p=0.05. The beta level will be set to 0.2. Since there is not a gold standard measure for adherence there also is not a minimal clinical change (MCD) or minimal clinical important difference (MCID) which could tell the difference in exercise adherence. Therefore, the authors will be only able to report the group differences and if they are significant or not. Effect sizes will be calculated to enlighten the clinical significance of these findings. The statistical analysis will be performed by the main researchers of this project under supervision. The data will be blinded and therefore the authors would not be biased. Both authors have taken several lectures of statistical analysis and will work in cooperation with their research supervisor. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06164847
Study type Interventional
Source Hochschule Osnabruck
Contact Susan Armijo-Olivo, PhD Professor
Phone +49 1522 3170807
Email susanarmijo@gmail.com
Status Recruiting
Phase N/A
Start date November 3, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT01401556 - C-STOP Fracture Trial N/A
Completed NCT01694784 - Understanding and Discouraging Overuse of Potentially Harmful Screening Tests N/A
Completed NCT01757340 - Calorie Restriction With Leucine Supplementation N/A